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Abstract 
A novel, green fluorescent β-alanylstyrylcoumarin derivative was synthesized and evaluated for its 
performance as a fluorogenic enzyme substrate on a range of clinically relevant microorganisms. The 
substrate was selectively hydrolysed by β-alanyl aminopeptidase producing P. aeruginosa resulting in 
an on-to-off fluorescent signal. Growth inhibitory effect of the substrate was observed on Gram 
positive bacteria and yeasts. Meanwhile, Gram negative species, despite their extremely protective cell 
envelope, showed ready uptake and accumulation of the substrate within their healthy growing 
colonies displaying intense green fluorescence.  
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Introduction 
Early-stage, low-cost and reliable detection and identification of pathogens in clinical settings is crucial in 
order to facilitate timely and informed decision-making to initiate appropriate therapy. Among the range of 
diagnostic methods which are available, chromogenic / fluorogenic culture media (exploiting specific 
bacterial enzyme activities) are still key components of clinical practice.1 These techniques are based on the 
incubation of bacterial isolates in the presence of chromogenic / fluorogenic enzyme substrates which can 
undergo enzymatic hydrolysis, consequently releasing an optical signal when and only when the 
microorganism of interest is present. For example, the incubation of the multidrug-resistant respiratory 
pathogens (Pseudomonas aeruginosa, Burkholderia cepacia, Serratia marcescens) in the presence of the 
yellow-coloured β-alanyl-pentylresorufamine (β-Ala-PRF) 1 (Figure 1a), produces purple colonies due to 
the formation of PRF 2 as a result of the specific β-alanyl aminopeptidase (BAP) activity they produce.2 
Despite such colorimetric methods often being acknowledged as the gold standard, due to their excellent 
sensitivity and specificity, reliable detection of the colour change against the background requires 24-72 
hours. However, application of fluorogenic substrates can reduce this waiting time to 6-8 hours due to the 
inherently more sensitive detection of fluorescence. For example, 7-hydroxy-4-methylcoumarin 4 was 
successfully converted into BAP substrate 3 (by the incorporation of a self-immolative linker) displaying 
blue fluorescence (λem 445 nm) upon hydrolysis by BAP within 6 hours (Figure 1b).3 
 
Figure 1. Detection of BAP producing P. aeruginosa using a) yellow coloured β-alanyl PRF 1 resulting in 
purple colonies upon enzymatic activity; b) non-fluorescent BAP substrate 3 resulting in blue fluorescent 
colonies upon hydrolysis by BAP. 
 
Coumarins are often used as fluorogenic core molecules for the detection of enzymatic processes due to their 
low toxicity and good cell-permeability as substrates, and their reasonable cell retention, allowing for 
localized signal release.4, 5 Moreover, sufficiently substituted coumarin-based substrates allow free enzymatic 
access to the targeting moiety (here, the β-alanyl fragment), which is essential for the hydrolysis and release 
of the signalling metabolic product.  
 
Scheme 2. Synthetic route for the preparation of substrate 10. Reagents and conditions: i) methyl 
(triphenylphosphoranylidene)acetate, 180 °C, 1 hr, inert atm.; ii) DMF, POCl3, 60 °C, 12 hrs, inert atmosphere; 
iii) 4-nitrobenzyltriphenylphosphonium bromide, CH3OH, CH3ONa, rt, 12 hrs; iv) iodine, chloroform, rt, 12 
hrs; v) SnCl2·H2O, EtOAc, 85 °C, 12 hrs. vi) Boc-β-alanine anhydride, DCM, DIPEA, 35 °C, 72 hrs. vii) TFA, 
DCM, 0 °C, 3 hrs. 
 
Designing substrates with hydrolysis products that emit outside of the blueish autofluorescence region of 
some naturally occurring peptide moieties remains a desired outcome. To enable this desirable red-shift 
(away from the autofluorescence range) we have designed a coumarin-based fluorophore 9 containing an 
electron donor diethylamino group, to enhance intramolecular charge transfer (ICT) and a styryl moiety, in 
order to extend conjugation associated with coumarins. Herein, we report the synthesis (Scheme 1) and 
evaluation of novel, green fluorescent β-alanylstyrylcoumarin derivative 10 with a green emission 
wavelength of 519 nm targeting BAP.  
Synthesis and characterization 
The synthetic route to obtain substrate 10 combined a series of well-established methods (Scheme 1); for 
the synthesis of 7-diethylaminocoumarin 6, a Wittig reaction6 between methyl 
(triphenylphosphoranylidene)acetate and 4-diethyl-aminosalicylaldehyde 5 resulted in a significantly higher 
yield in comparison to the conventional Knoevenagel condensation7 (see Section 5.1.1.). Introduction of the 
formyl functionality onto position 3 of the coumarin ring (7) involved a Vilsmeier-Haack formylation via a 
previously reported procedure.7 A para-nitrostyryl moiety was then introduced into coumarin 7 for the dual 
purpose of extending the conjugation and facilitating the covalent attachment of the β-alanine enzyme 
targeting moiety. To achieve this, a Wittig reaction8 using p-nitrobenzyl triphenylphosphonium ylide gave 
higher yield of 8 than the condensation between p-nitrophenylacetic acid and coumarin 7 (see Section 
5.1.2.).4, 9 The approx. 1:1 mixture of (Z)- and (E)-7-diethylamino-3-(4-nitrostyryl)coumarin 8 obtained was 
converted into the sole (E)-isomer product via isomerization in the presence of iodine.10 To enable attachment 
of β-alanine (the N-terminal recognition site for BAP), reduction of the nitro group was carried out (using 
stannous chloride) to give amine 9. This was followed by amide bond formation11 and consequent Boc-
deprotection to obtain BAP substrate 10 as a TFA salt.12 This cationic form of the substrate is proven to 
facilitate water solubility and cell permeability.13 In vitro fluorescence of the nitro 8, amine 9, and amide 10 
derivatives were firstly recorded in THF at a concentration of 1 x 10-4 M (Figure 2 and Figure S1). A change 
in the substituent at the para-styryl position, from the strongly electron withdrawing nitro group in 8 to the 
electron donating amine in 9 and amide in 10, resulted in the blue shift of the emission wavelength from 574 
to 510 nm and 497 nm, respectively. A significant increase in emission intensity was also observed from -
NO2 8 < -NH2 9 < amide 10. In aqueous THF 1:1 mixtures fluorescence emission of both nitrostyrylcoumarin 
8 and amino derivative 9 were quenched, while substrate 10 displayed an intense green fluorescence, with an 
emission maximum of 519 nm (Figure 2). In general, the bright fluorescence of 7-dialkylamino-coumarins 
is a result of excited state ICT enhanced by the strongly electron donating dialkylamino group.14 However, 
especially in polar solvents, when a strongly electron withdrawing group (such as nitro) is conjugated via 
position 3 of the coumarin ring, the enhanced push-pull effect of the EDG-EWG substituents stabilizes this 
charge separation in the excited state, thus opening up the possibility of non-radiative twisted intramolecular 
charge transfer (TICT) decay and consequently resulting in the weakening of the fluorescence emission 
intensity, as is observed in the case of the nitro derivative 8.15 The strength of the push-pull effect across the 
coumarin ring has been reported to narrow the HOMO-LUMO gap, thus resulting in a red shift of the 
emission wavelength. Although, amine 9 and substrate 10 both have electron donating substituents, amides 
are much less electron donating than amines, hence they displayed rather different fluorescence properties. 
The above ICT process was described between the 7-diethylamino and coumarin carboxyl moieties. When 
the styryl-amino lone pair is occupied in the amide resonance structures of 10, bright green fluorescence is 
displayed. However, in amine 9, the freely available amino lone pair is presumed to reduce the probability of 
ICT, resulting in an ‘isolated’ diethylamino rotor, and allowing for non-radiative decay pathways (Figure 
3).5 Due to these observed properties, instead of the often-exploited fluorescence quenching by the amide 
bond-formation,16 substrate 10 would provide ‘on-to-off’ signalling of BAP activity.  
       
 λex (nm) 
λem 
(nm) 
Int 
(a.u.) 
 THF 
8 522 574 26 
9 497 510 70 
10 473 497 192 
 THF/H2O 
9 na na 0 
10 482 519 200 
Figure 3. Emission of amine 9 (purple) in THF (dotted line) (λex: 497 nm), and in THF:water 1:1 (solid line); 
Emission of substrate 10 (green) in THF (dotted line) (λex: 473 nm), and THF:water 1:1. (solid line) (λex: 482 
nm). 
 
 
Biological evaluation 
Substrate 10 was incorporated into both solid agar-based and liquid growth media for their incubation with 
microorganisms. The agar plates were subjected to in vivo evaluation on both multispot inoculation and 
individually streaked clinical isolates of commonly encountered pathogens. For the multispot inoculation, 10 
Gram negative (spots no. 1-10), 8 Gram positive bacteria (spots no. 11-18), and 2 yeasts (spots no. 19-20) 
(Figure 4a) were selected as representative cell lines for the clinical evaluation. Colonies of Gram negative 
E. coli, S. enteritidis, P. aeruginosa, and Gram positive S. aureus, and E. faecalis were streaked on individual 
plates (Figure 4b, Figure S2). There are two apparent effects of the incorporation of substrate 10 into the 
growth media; the growth of all Gram positive bacteria and yeast species was inhibited, while the Gram 
negative species formed colonies (Figure 4a-iii, Table S1), and secondly, Gram negative cell lines displayed 
intense green fluorescence as a result of accumulating substrate 10 within the colonies (Figure 4a-iv). 
Moreover, as was suggested by the in vitro fluorescence studies in aqueous solution (Figure 2), BAP 
producing P. aeruginosa displayed non-fluorescent colonies due to the hydrolysis of substrate 10 to non-
fluorescent metabolic product 9 (Figure 4b). This change provides a ready visual differentiation between 
BAP and non-BAP producing Gram negative species. 
Preliminary results in liquid growth media confirmed these results described above; the pathogens were 
the Gram negative non-BAP producing E. coli, BAP producing S. marcescens, B. cepacia, and P. aeruginosa, 
as well as Gram positive S. aureus. The pathogens were incubated, in the absence and presence, of substrate 
10 in a well plate for 20 hours before determining optical densities (OD) by measuring the increase in 
absorbance intensity at 690 nm, and the fluorescence intensity increase (λex 365 nm, λem 460 nm) (Table S2, 
Figure S3). OD values confirmed the growth inhibitory effect of the substrate on S. aureus, along with weak 
suppression of OD of Gram negative S. marcescens and P. aeruginosa (Figure S3a). Substrate 10 exhibited 
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Figure 4. Proposed resonance structures resulting in ICT in substrate 10, and inhibition of ICT in amine 9. 
a background fluorescence as measured in the blank control wells containing no microorganisms (Figure 
S3b). Non-BAP producing E. coli, and BAP producing S. marcescens displayed increased green fluorescence 
within the time frame of the test. Although S. marcescens and B. cepacia express BAP, its activity is 
significantly lower than that of P. aeruginosa.17 Substrate 10 is thus virtually unhydrolysed by S. marcescens, 
and partly hydrolysed by B. cepacia within the time frame of this study. The expression of BAP by P. 
aeruginosa is apparent through the quenched fluorescence of substrate 10 via its hydrolysis to non-
fluorescent metabolic product 9. Wells inoculated with S. aureus displayed equal fluorescence intensity to 
that of the blank wells, confirming that there was no growth of these Gram positive microorganisms.
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fluorescence of substrate 10 
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E. coli S. enteritidis P. aeruginosa 
 
Gram positive organisms 
Growth inhibitory effect of substrate 10 on 
Gram positive organisms 
  
S. aureus E. faecalis 
 
 Organism  Organism 
1 E. coli 11 S. pyogenes 
2 K. 
pneumoniae 
12 S. aureus 
(MRSA) 
3 P. rettgeri 13 S. aureus 
4 E. cloacae 14 S. 
epidermidis 
5 S. marcescens 15 L. 
monocytog
enes 
6 S. 
typhimurium 
16 E. faecium 
7 P. aeruginosa 17 E. faecalis 
8 Y. 
enterocolitica 
18 B. subtilis 
9 B. cepacia 19 C. albicans 
10 A. baumannii 20 C. glabrata 
 
 
Figure 5. a) Multispot inoculation Columbia agar plates with isolates after 20 hours of incubation. i) Numbered 
spots correlating to species named in the table and ii) corresponding microorganisms in the absence of 
substrate 10; iii) in the presence of substrate 10 (50 mg/L) under VIS light, and iv) under 365 nm light source; 
b) Streaked Columbia agar plates containing substrate 10 (50 mg/L) under UV light (365 nm) after 20 hours 
incubation in the presence of (from top left to bottom right): Gram negative non-BAP producing E. coli and 
S. enteritidis, BAP producing P. aeruginosa, and Gram positive S. aureus (inhibited) and E. faecalis 
(inhibited).
 Although substrate 10 was metabolized by the targeted enzyme, BAP, it displayed on-to-off rather than 
the more desirable off-to-on fluorescence. However, the combination of selective growth (enrichment) of 
Gram negative organisms, and the display of intense green fluorescence upon accumulation by viable 
colonies provides substrate 10 with a highly sought after dual role. These attributes exhibited by the same 
enzyme substrate can assist the every-day clinical task of isolating and identifying multi-drug resistant Gram 
negative pathogens. Furthermore, Gram negative bacteria exhibit greater resistance to most known antibiotics 
due to a combination of the effect of their complex outer membrane providing low permeability, and their 
multidrug efflux pumps deterring the intracellular accumulation of drugs.18 Thus, the combination of cellular 
uptake and accumulation of substrate 10 by Gram negative species can be exploited as a lead towards 
identifying molecular structural requirements for both intracellular uptake and retention by Gram negative 
species. 
Conclusion 
In conclusion, a novel β-alanylstyrylcoumarin aminopeptidase substrate 10 was synthesized and 
characterized. Substrate 10 displayed intense green fluorescence (outside the inherent autofluorescence 
region) upon localization within Gram negative bacterial colonies, while inhibited the growth of all tested 
Gram positive bacteria and yeasts. Thus, this compound has the potential to be exploited as a selective 
enrichment agent and a detection tool at the same time. Selective detection of BAP activity (specific to P. 
aeruginosa) was achieved via fluorescence quenching, instead of the more desired off-to-on signal 
generation. More significantly, the substrate was taken up and retained by Gram negative colonies. This is 
an essential requirement for both diagnostic enzyme substrates for the localization of the detection signal, 
and for therapeutic agents to reach and act on their intracellular targets. Additionally, exchange of the β-
alanine targeting moiety for other amino acids, or the modification of the fluorescent coumarin allow for the 
design of customized agents for the detection, selective growth, or advanced cellular uptake of other 
microorganisms. 
Experimental 
Synthetic chemistry 
All solvents and reagents were obtained from Sigma-Aldrich (Castle Hill, Sydney, Australia) and used 
without any further purification or treatment. The THF for the fluorescence measurements specifically 
contained no fluorescent stabilizers. Thin layer chromatography was performed on silica gel plates from 
Grace Davison Discovery Sciences (US). Column chromatography was performed on a Grace Reveleris X2. 
1H and 13C NMR spectra were obtained on a Varian 400MR at 400 MHz and 100 MHz, respectively. 
Coupling constants (J) are in Hertz (Hz), and chemical shifts (δ) are expressed in parts per million (ppm) and 
reported relative to residual solvent peaks. Melting points were recorded on a Stuart Scientific SMP 10. 
Infrared spectra were obtained on Shimadzu FTIR IR Tracer-100 and Shimadzu FTIR-8400S 
spectrophotometers.  
Excitation and emission spectra were obtained on a Shimadzu RF-5301PC spectrophotometer. Microwave 
reactions were performed on CEM Discover. Low resolution mass spectra were obtained on Thermo 
Scientific TSQ Quantum Access Max LCMS/MS & TLX1 Turboflow Chromatography System in positive 
ion mode. High resolution mass spectra were generated on Bruker 7T Fourier Transform Ion Cyclotron 
Resonance Mass Spectrometer (FTICR) in positive ion mode.  
Synthesis of 7-diethylaminocoumarin 6 
Method A: 4-Diethylaminosalicylaldehyde 5 (0.773 g, 4 mmol) was dissolved in ethanol (30 mL), then 
1,8-diazabicycloundec-7-ene (DBU) (1.5 mL) and diethylmalonate (1.5 mL) were added. The mixture was 
stirred for 6 hours at 80 °C. The ethanol was removed under vacuum and glacial acetic acid (20 mL) and 
concentrated HCl (37%) (20 mL) were added to the reaction, which was stirred overnight at 75 °C. The 
reaction mixture was cooled to room temperature and poured into ice water (50 mL). Aq. NaOH solution (5 
mol/L) was added dropwise to the mixture to adjust the pH of the solution to 5. The precipitate formed was 
filtered, and washed with water to give a carboxylic acid intermediate (0.314 g, 36 %). 1H NMR (400 MHz, 
CDCl3) δ: 1.25 (6H, t, J = 7.2 Hz, 2 × CH3), 3.48 (4H, q, J = 7.2 Hz, 2 × CH2), 6.51 (1H, d, J = 2.4 Hz, Ar-
H), 6.70 (1H, dd, J = 8.8, 2.4 Hz, Ar-H), 7.44 (1H, d, J = 8.8 Hz, Ar-H), 8.64 (1H, s, Ar-H); 13C NMR (100 
MHz, CDCl3) δ: 12.4, 45.3, 96.8, 105.6, 108.6, 110.9, 131.9, 150.3, 153.8, 158.0, 164.5, 165.5; LRMS (ESI) 
m/z 262 (MH+). This carboxylic acid intermediate (0.314 g, 1.45 mmol) was then further reacted with glacial 
acetic acid (5 mL) and HCl (5 mL) at 120 °C overnight. The reaction was cooled to room temperature and 
poured over ice water (50 mL). Aq. NaOH solution (5 mol/L) was added to the mixture dropwise to adjust 
pH of the solution to 5. The precipitate formed was filtered, and washed with water to give product 6 as a 
dark brown solid (0.158 g, 18 %).7  
Method B: A mixture of 4-diethylaminosalicylaldehyde 5 (1 g, 5.17 mmol) and methyl 
(triphenylphosphoranylidene)acetate (2 g, 5.96 mmol) was heated at 180 °C under nitrogen for 1 hour. The 
mixture was cooled to room temperature. On the obtained solid mixture column chromatography was 
performed using hexane : ethyl acetate (10 to 15% ethyl acetate ) to give product 6 as a light orange solid 
(0.749 g, 67 %).6 Mp 87-88 °C; 1H NMR (400 MHz, CDCl3) δ: 1.20 (6H, t, J=7.2 Hz, 2 × CH3), 3.40 (4H, 
q, J=7.2 Hz, 2 × CH2), 6.02 (1H, d, J=9.6 Hz, Ar-H3), 6.48 (1H, d, J=2.4 Hz, Ar-H8), 6.56 (1H, dd, J=8.8, 
2.4 Hz, Ar-H6), 7.23 (1H, d, J=8.8 Hz, Ar-H5), 7.52 (1H, d, J=9.6 Hz, Ar-H4); 13C NMR (100 MHz, CDCl3) 
δ: 12.4 (2 × CH3), 44.8 (2 × CH2), 97.6 (CH), 108.3 (quat.), 108.6 (CH), 109.2 (CH), 128.7 (CH), 143.7 (CH), 
150.7 (quat.), 156.7 (quat.), 162.3 (C=O); IR (υmax/cm-1): 1701 (C=O); LRMS (ESI) m/z 218 (MH+); HRMS 
(ESI) m/z found: MNa+, 240.0997; Calcd. for C13H15NO2Na+ , 240.0995. 
Synthesis of 7-diethylaminocoumarin-3-carbaldehyde 7 
Anhydrous DMF (6 mL) was added dropwise to POCl3 (6 mL) in an ice water bath and the mixture was 
stirred for 30 minutes under nitrogen. 7-Diethylaminocoumarin 6 (1.5 g, 6.91 mmol) was dissolved in DMF 
(15 mL) and the solution was then added dropwise to the above solution. The mixture was stirred at 60 °C 
overnight under nitrogen, and poured into ice water(50 mL). Aq. NaOH solution (5 mol/L) was added 
dropwise to adjust the pH of the mixture to about 6, resulting in a precipitate which was filtered to give 
product 7 as an orange solid (0.993 g, 59 %).7 Mp 162-164 °C; 1H NMR (400 MHz, CDCl3) δ: 1.25 (6H, t, 
J=7.2 Hz, 2 × CH3), 3.47 (4H, q, J=7.2 Hz, 2 × CH2), 6.48 (1H, d, J=2.4 Hz, Ar-H8), 6.63 (1H, dd, J=8.8, 
2.4 Hz, Ar-H6), 7.40 (1H, d, J=8.8 Hz, Ar-H5), 8.24 (1H, s, Ar-H4), 10.12 (1H, s, CHO); 13C NMR (100 
MHz, CDCl3) δ: 12.4 (2 × CH3), 45.3 (2 × CH2), 97.2 (CH), 108.3 (quat.), 110.2 (CH), 114.4 (quat.), 132.5 
(CH), 145.3 (CH), 153.4 (quat.), 158.9 (CH), 161.9 (C=O), 187.9 (CHO); IR (υmax/cm-1): 1701 (C=O), 1670 
(CHO); LRMS (ESI) m/z 246 (MH+); HRMS (ESI) m/z found: MNa+, 268.0946; Calcd. for C14H15NO3Na+, 
268.0944. 
Synthesis of (E)-7-diethylamino-3-(4-nitrostyryl)coumarin 8 
Method A: A mixture of 7-diethylaminocoumarin-3-aldehyde 7 (245 mg, 1 mmol), 2-(4′-
nitrophenyl)acetic acid (207 mg, 1.15 mmol) and piperidine (196 mg, 2.3 mmol) was stirred for 1.5 hours at 
140 °C under reflux. The reaction mixture was cooled to room temperature then ethanol (15 mL) was added 
and sonicated for 10 minutes. The mixture was then stirred overnight and the precipitate was filtered under 
vacuum, washed with ethanol (3 mL) and hexane (3 mL) resulting in coumarin 8 as a dark red solid (7 mg, 2 
%).4 
Method B: A mixture of 7-diethylaminocoumarin-3-aldehyde 7 (50 mg, 0.204 mmol), 2-(4-
nitrophenyl)acetic acid (40.9 mg, 0.226 mmol), imidazole (21 mg, 0.308 mmol), piperidine (26.2 mg, 0.308 
mmol) and ethylene glycol (0.6 mL) was stirred under microwave irradiation at i) 150W, 160 °C) or ii) 300W, 
160 °C for 30 minutes. Both reaction mixtures were cooled to room temperature and acidified with HCl (1 
mol/L) to adjust the pH to 5. The aqueous solution was then extracted with ethyl acetate (2- mL), which was 
separated and dried over sodium sulfate. The organic layer was evaporated, ethanol (10 mL) was added and 
sonicated for 90 minutes to form a precipitate, which was then filtered under vacuum, washed with ethanol 
(3 mL) and hexane (3 mL) resulting in a dark red solid 8 (5 mg, 7 %).9 
Method C: Synthesis of 4-nitrobenzyltriphenylphosphonium bromide: 4-Nitrobenzyl bromide (3 g, 13.89 
mmol) was dissolved in toluene (50 mL), then triphenylphosphine (3.643 g, 13.89 mmol) was added and the 
mixture was heated at 120 °C overnight. The product was filtered under vacuum, washed with hexane (50 
mL) to give a fine white powdered solid (6.333 g, 13.18 mmol, 95 %).19 Mp 273-274 °C; 1H NMR (400 
MHz, CDCl3) δ: 5.99 (2H, d, J=15.6 Hz, Ar-H), 7.45 (2H, dd, J=7.2, 2.8 Hz, Ar-H), 7.56-7.84 (17H, m, Ar-
H); LRMS (ESI) m/z 398 (M+); HRMS (ESI) m/z found: M+, 398.1306; Calcd. for C25H21NO2P+, 398.1304.  
Synthesis of (E)-7-diethylamino-3-(4-nitrostyryl)coumarin 8: In a round bottom flask fitted with drying tube, 
7-diethylaminocoumarin-3-aldehyde 7 (0.8 g, 3.2 mmol) and 4-nitrobenzyltriphenylphosphonium bromide 
(1.872 g, 3.92 mmol) were dissolved in dry methanol (80 mL) and then CH3ONa (0.96 g, 17.6 mmol) was 
added. The mixture was stirred at room temperature overnight and was then poured into ice water (160 mL), 
and stirred for 2 hours at room temperature. The solid was filtered under vacuum and triturated with ethanol 
(3 × 100 mL) resulting in a mixture of the (E) and (Z) isomers of 8 (0.743 g, 62.5%). This mixture of (E) and 
(Z)-8 (743 mg, 2.036 mmol) was dissolved in chloroform (60 mL) in a round bottom flask fitted with drying 
tube then iodine (103.43 mg, 0.204 mmol) was added and the reaction mixture was stirred at room 
temperature overnight. The solution was washed thoroughly with saturated sodium metabisulfite solution (5 
× 20 mL). The organic layer was dried over sodium sulfate and evaporated under reduced pressure to give 
the product (E)-8 as a dark red solid (743 mg, 100 %).8, 10 Mp 259-260 °C (lit. 253-255 °C); 1H NMR (400 
MHz, CDCl3) δ: 1.23 (6H, t, J=7.2 Hz, 2 × CH3), 3.44 (4H, q, J=7.2 Hz, 2 × CH2), 6.51 (1H, d, J=2.4 Hz, 
Ar-H8), 6.62 (1H, dd, J=8.8, 2.4 Hz, Ar-H6), 7.19 (1H, d, J=16 Hz, CHA or CHB), 7.31 (1H, d, J=8.8 Hz, 
Ar-H5), 7.59 (1H, d, J=16 Hz, CHA or CHB), 7.61 (2H, d, J=8.8 Hz, Ar-H2′,6′), 7.71 (1H, s, Ar-H4), 8.19 
(2H, d, J=8.8 Hz, Ar-H3′,5′); 13C NMR (100 MHz, CDCl3) δ: 12.5 (2 × CH3), 45.0 (2 × CH2), 97.2 (CH), 
108.9 (quat.), 109.4 (CH), 116.4 (quat.), 124.1 (CH-2′,6′ or CH-3′,5′), 126.8 (CH-2′,6′ or CH-3′,5′), 127.6 
(CH), 128.0 (CH), 129.3 (CH), 140.5 (CH), 144.4 (CH), 146.5 (quat.), 151.0 (quat.), 156.0 (quat.), 161.0 
(C=O); IR (υmax/cm-1): 1705 (C=O), 1616 (C=C), 1519 (NO2), 1331 (NO2); LRMS (ESI) m/z 365 (MH+); 
HRMS (ESI) m/z found: M+, 364.1421 and MH+, 365.1500; Calcd. for C21H20N2O4, 364.1418 and for 
C21H21N2O4+, 365.1451. 
Synthesis of (E)-3-(4-aminostyryl)-7-(diethylamino) coumarin 9 
(E)-7-Diethylamino-3-(4-nitrostyryl)coumarin 8 (200 mg, 0.549 mmol) and SnCl2·H2O (1.23 g, 5.49 
mmol) in ethyl acetate (10 mL) was refluxed overnight. Saturated Na2CO3 was added to adjust the pH to 10. 
Ethyl acetate (20 mL) was added to the mixture which was then filtered through celite, and washed with ethyl 
acetate (60 mL). The organic layer was dried over sodium sulfate and evaporated under vacuum resulting in 
the product 9 as a dark orange solid (182 mg, 99 %). 4 Mp 188-192 °C (lit. 166-168 °C); 1H NMR (400 MHz, 
DMSO-d6) δ: 1.13 (6H, t, J=7.2 Hz, 2 × CH3), 3.44 (4H, q, J=7.2 Hz, 2 × CH2), 5.33 (2H, broad s, NH2), 
6.54 (1H, d, J=2.4 Hz, Ar-H8), 6.57 (2H, d, J=8.8 Hz, Ar-H3′,5′), 6.71 (1H, dd, J=8.8, 2.4 Hz, Ar-H6), 6.79 
(1H, d, J=16.4 Hz, CHA or CHB), 7.23 (2H, d, J=8.4 Hz, Ar-H2′,6′), 7.29 (1H, d, J=16.4 Hz, CHA or CHB), 
7.43 (1H, d, J=9.2 Hz, Ar-H5), 7.93 (1H, s, Ar-H4); 13C NMR (100 MHz, DMSO-d6) δ: 13.0, 44.7, 97.0, 
109.3, 109.9, 114.6, 117.9, 118.0, 125.6, 128.1, 129.6, 130.8, 137.3, 149.5, 150.5, 155.4, 161.2; IR (υmax/cm-
1): 3456 (NH2), 3360 (NH2), 1686 (C=O), 1605 (C=C); LRMS (ESI) m/z 335 (M+); HRMS (ESI) m/z found: 
M+, 334.1677 and MH+, 335.1756; Calcd. for C21H22N2O2, 334.1676 and for C21H23N2O2+, 335.1754. 
Synthesis of (E)-3-(4-β-alanylstyryl)-7-(diethylamino) coumarin trifluoroacetate 10 
Boc-β-alanine (508.97 mg, 2.69 mmol) was added to dicyclohexylcarbodiimide (610.53 mg, 2.959 mmol) 
dissolved in DCM (10 mL) and stirred in an ice bath for 3 hours. The reaction mixture was filtered and the 
filtrate was added into a mixture of (E)-3-(4-aminostyryl)-7-(diethylamino)coumarin 9 (300 mg, 0.897 mmol) 
and diisopropyl ethyl amine (DIPEA) (197.08 mg, 1.525 mmol) in DCM (20 mL). The mixture was heated 
at 35 °C over 72 hours. Aqueous HCl (1 mol/L, 10 mL) was added and the organic layer was washed with 
saturated NaHCO3 solution (10 mL) then dried over sodium sulfate and filtered under reduced pressure to 
give a yellow solid (214 mg, 47 %).11 Mp 216-218 °C; 1H NMR (400 MHz, DMSO-d6) δ: 1.14 (6H, t, J= 7.2 
Hz, 2 × CH3), 1.39 (9H, s, 3 × CH3), 2.47-2.52 (2H, m, CH2-C or CH2-D), 3.23 (2H, m, J=6.8, 6.0 Hz, CH2-C 
or CH2-D), 3.45 (4H, q, J=7.2 Hz, 2 × CH2), 6.56 (1H, d, J=2.4 Hz, Ar-H8), 6.73 (1H, dd, J=6.8, 2.4 Hz, Ar-
H6), 6.86 (1H, t, J=5.2 Hz, NH), 7.02 (1H, d, J=16.4 Hz, CHA or CHB), 7.42 (1H, d, J=16.4 Hz, CHA or 
CHB), 7.45-7.48 (3H, m, 3 × Ar-H), 7.61 (2H, d, J=8.8 Hz, Ar-H3′,5′), 8.03 (1H, s, Ar-H4), 10.01 (1H, s, 
NH); 13C NMR (100 MHz, DMSO-d6) δ: 13.0, 28.9, 37.1, 37.4, 44.7, 78.2, 96.9, 109.1, 110.0, 117.0, 119.9, 
122.5, 127.3, 129.5, 129.9, 132.8, 139.4, 150.9, 155.8, 156.2, 161.0, 170.0; IR (υmax/cm-1): 1709 (C=O), 1667 
(C=O), 1616 (C=C), 1593 (amide I), 1508 (amide II); LRMS (ESI) m/z 506 (MH+); HRMS (ESI) m/z found: 
M+, 505.2573 and MH+, 506.2607; Calcd. for C29H35N3O5, 505.2571 and for C29H36N3O5+, 506.2605. 
The obtained (E)-3-(4-tert-butoxycarbonylamino-propanamidostyryl)-7-(diethylamino)coumarin (150 mg, 
0.297 mmol) was dissolved in DCM (10 mL) on an ice bath. A mixture of trifluoroacetic acid (2 mL) and 
DCM (2 mL) was added dropwise. The reaction was then allowed to warm to room temperature and stirred 
for 3 hours. The reaction mixture was concentrated in vacuo then methanol (2 × 10 mL) and the mixture was 
concentrated in vacuo (for the removal of residual TFA). The reaction mixture was triturated with diethyl 
ether twice and the solid was filtered and washed with diethyl ether (20 mL) resulting in product 10 as an 
orange solid (132 mg, 86 %).12 Mp 222-226 °C; 1H NMR (400 MHz, DMSO-d6) δ: 1.14 (6H, t, J= 7.2 Hz, 2 
× CH3), 2.72 (2H, t, J= 6.8 Hz, CH2-C or CH2-D), 3.11 (2H, t, J=6.8 Hz, CH2-C or CH2-D), 3.45 (4H, q, J=7.2 
Hz, 2 × CH2), 6.56 (1H, d, J=2.4 Hz, Ar-H8), 6.74 (1H, dd, J=8.8, 2.4 Hz, Ar-H6), 7.03 (1H, d, J=16.4 Hz, 
CHA or CHB), 7.41-7.51 (4H, m, CHA or CHB and 3 × Ar-H), 7.62 (2H, d, J=8.8 Hz, Ar-H3′,5′), 7.76 (3H, 
broad s, NH3+), 8.03 (1H, s, Ar-H4), 10.23 (1H, s, NH); 13C NMR (100 MHz, DMSO-d6) δ: 12.8, 33.8, 35.4, 
44.6, 96.8, 108.9, 109.9, 116.8, 119.8, 122.6, 127.3, 129.2, 129.8, 133.0, 138.8, 139.3, 150.8, 155.6, 160.8, 
168.8; IR (υmax/cm-1): 3325 (NH3+), 1697 (C=O), 1670 (C=C), 1585 (amide I), 1508 (amide II); LRMS (ESI) 
m/z 406 (M+); HRMS (ESI) m/z found: M+, 406.2126; Calcd. for C24H28N3O3+, 406.2125. 
In vitro fluorescence properties 
The concentration of stock solution for (E)-3-(4′-nitrostyryl)-7-(diethylamino)coumarin 8, (E)-3-(4′-β-
alanylstyryl)-7-(diethylamino)coumarin trifluoroacetate 10 and (E)-3-(4′-aminostyryl)-7-
(diethylamino)coumarin 9 was 2 × 10-4 mol/L in THF. 2 mL of THF, or 2 mL water was added to 2 mL of 
the stock solution of each compound, respectively. The slit width of fluorescence spectrophotometer was set 
at 3 mm. 
Biological evaluation 
Solid agar media 
Preparation of culture media containing substrate. Columbia agar was prepared as follows; 41 g of Columbia 
agar (Oxoid Basingstoke, UK) was added to deionized water and the volume was made up to 1 L. The medium 
was sterilized by autoclaving at 116 °C for 20 minutes and left to cool at 50 °C. 2 mg of the substrate to be 
tested was initially dissolved in 100 μL of N-methylpyrrolidone and this was added to Columbia agar (made 
up to 20 mL), then poured into sterile Petri dishes to give a final concentration of 100 mg/L for the substrates. 
Columbia agar incorporating an equivalent concentration of N-methylpyrrolidone was used as a growth 
control.  
Microbial suspension preparation. Microbial reference strains were obtained from either the National 
Collection of Type Cultures (NCTC) or the National Collection of Pathogenic Fungi (NCPF) which are both 
located at the Central Public Health England Laboratory, Colindale, UK or the American Type Culture 
Collection (ATCC), Manassas, USA. The 20 test microorganisms were maintained on Columbia agar. 
Multipoint inoculation. Colonies of each microbial strain were harvested using a loop from overnight cultures 
on Columbia agar. These were suspended in sterile deionized water to a suspension equivalent to 0.5 
McFarland units using a densitometer. 100 μL of this suspension was pipetted into the corresponding wells 
of a multipoint inoculation device. Each set of plates received 1 μL of bacterial suspension, giving 1.5 × 105 
organisms per spot on each inoculation. Twenty strains were inoculated per plate and the plates were 
incubated for 18 hours in air at 37 °C. 
Activity determination. After incubation, the activity of the microorganisms with the test substrates was 
determined by observing the plates under UV irradiation at 365 nm and comparing with the substrate-free 
control.  
Liquid media 
For the evaluation of substrates 8, 9, and 10 in liquid media, N-methyl-2-pyrrolidinone (NMP) was 
purchased from ACROS ORGANICS. Trypcase Soy Broth (TSB BIOMERIEUX ref. 42 100) and 
Suspension Medium BIOMERIEUX (ref. 70 640) were used. Microplate reader TECAN Infinite M-200 was 
used to record fluorescence (365/460 setting) and absorption (at 690 nm for organism density). After a 20 
hour period of incubation of the assessed strains (Table S2 and S3) on GREINER 96 well plate (ref. 655 090) 
sealed with transparent GREINER viewseal (ref. 676 070). For 8, 9 and 10, a 10 µL solution of substrate (at 
50g/L in NMP) was suspended in 5 mL of TSB (final concentration 100 mg/L). Every well was filled with 
100 µL of specified solution of substrate and 100 µL of bacterial suspension at 0.5 McFarland for a final 
concentration of 0.25 McFarland (about 7.5 × 107 bacteria/mL). For control, in the absence of enzyme 
substrates the wells were filled with 100 μL TSB and 100 µL of bacterial suspension at 0.5 McFarland. For 
negative control (blank), the wells were filled with 100 µL TSB in the absence or presence of any of the 
substrates and 100 µL Suspension Medium. The absorption (at 690 nm for microbial growth) and relative 
fluorescent intensities (at λex= 365 nm / λem= 460 nm) for enzymatic activity were recorded after a period of 
20 hours. 
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